Polymorphic Compound (S) - 3 - (1 - (9H purin - 6 - ilamino) ethyl) - 8 - 2 - chlorine - fenilisoquinolin - 1 - (2H) - one of forms B J, Amorphous, Salt, hydrate or solvate thereof； mixtures of these Compounds, method for preparing the Polymorph Pharmaceutical Composition of c；； Treatment method； use for Treatment (d And a disorder mediated by PI3K.

• 收藏
• 分享

专利权人:

INFINITY PHARMACEUTICALS; INC.

发明人:

REN PINGDA,MARTIN MICHAEL,ISBESTER PAUL,LANE BENJAMIN S,KROPP JASON

申请号：

CL2013002007

公开号：

CL2013002007A1

申请日:

2013.07.09

申请国别(地区):

CL

年份:

2014

代理人:

摘要：

Polymorphs of chemical compounds that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI 3 kinase activity, are described herein. Also provided herein are processes for preparing compounds, polymorphs thereof, and pharmaceutical compositions thereof.FORMA POLIMÓRFICA C DE (S)-3-(1-(9H-PURIN-6-ILAMINO)ETIL)-8-CLORO-2-FENILISOQUINOLIN-1(2H)-ONA； MÉTODO DE PREPARACIÓN； COMPOSICIÓN FARMACÉUTICA； Y SU USO PARA TRATAR TRASTORNOS MEDIADOS POR PI3K, TALES COMO UNA ENFERMEDAD INFLAMATORIA O AUTOINMUNE.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/